| Literature DB >> 34220107 |
Pranab Paul1, Md Rayhan Faruque1, Md Kaisar Rahman2, Priyanka Das3, Mohammed Yousuf Elahi Chowdhury1.
Abstract
BACKGROUND AND AIM: Goat is one of the major livestock species, plays an important role in the economy of Bangladesh. However, the outbreak of different infectious diseases in goats causes high mortality and economic losses due to lack of proper diagnosis and treatment. Conventional culture-based methods for detecting specific pathogens as confirmatory diagnosis are laborious as well as time-consuming in comparison to multiplex polymerase chain reaction (mPCR), by which multiple pathogens can be detected at a time. The present study was aimed to perform faster molecular identification of bacterial pathogens from goats presumed with fever and/or diarrhea and their antimicrobial resistance (AMR) pattern.Entities:
Keywords: antimicrobial resistance; goat; infectious disease; multiplex polymerase chain reaction; prevalence
Year: 2021 PMID: 34220107 PMCID: PMC8243672 DOI: 10.14202/vetworld.2021.1080-1092
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Primer sequence of bacterial toxin genes.
| Bacteria | Toxins | Primer sequence | Size |
|---|---|---|---|
| Lambda DNA | lambda-F | CGCGAATATGCCGGTTATCA | 1000bp |
| lambda-R | CACGGAGTAGCCGTTATCCGT | ||
| invA-F | TCATATTACGCACGGAAACACGTTC | 100bp | |
| invA-R | CCTGATTTACTTAAAGAAGTGCTCAG | ||
| prfA-F | GGAGTTTCTTTACCATACACATAGGTC | 150bp | |
| prfA-R | TCTTACGCACTTTTTCTATGTTTTCCAAA | ||
| hblC-F | CTCTCGCAACACCAATCGTTCA | 200bp | |
| hblC-R | CCATTCCTTCATATCTTGTTTGATTAG | ||
| bceT-F | TTCAGTTCAAAGAAGCATGGACGAAAG | ||
| bceT-R | ATGCTGACGAGCTACATCCATAATGACT | ||
| nheA-F | ACAGGGTTATTGGTTACAGCAGTATC | ||
| nheA-R | TCTGGCTGTTGCAAAATAAYTAATCC | ||
| entFM-F | TGTTCGTTCAGGTGCTGGTACAGG | ||
| entFM-R | ACTGTGTAAGTACCWGTTCCTTGTTGAA | ||
| cytK-F | AGGGATTGGGTAGTTATCAATAGG | ||
| cytK-R | TCGGGCAAAATGCAAAAACACATACG | ||
| CER-F | GGGACCAAGAAACGAAAAAGAAGCA | ||
| CER-R | AGTTCAGCAATCGTTTGATACTGAAAG | ||
| inv (Y)-F | GGCAAATCAGGAAGTAAAACACTGG | 250bp | |
| inv (Y)-R | TGTCATAGAAAGTGTTAAAGCCATAC | ||
| hipO-F | TCTGGAGCACTTCCATGACCACC | 300bp | |
| hipO-R | TTGCGGTCATGATGGACATACTAC | ||
| glyA-F | TCAAGGCGTTTATGCTGCACTTTTAA | ||
| glyA-R | GCAATGTCTGCAAAAAGATAAGCTCCAAC | ||
| cpe-F | TGGATTTGGAATAACTATAGGAGAAC | 400bp | |
| cpe-R | AGTCCAAGGGTATGAGTTAGAAGAACG | ||
| cpb2-F | AGCAATAAGTCCAATGAAAGCAAGTGC | ||
| cpb2-R | ACAAACTTGAGTTCTAAATGATGGTGT | ||
| hly-F | AGCAGAGATGCAAGCCCAATTCAG | 500bp | |
| hly-R | TGGCTCCAAACTGACGATAACCGAG | ||
| vvha-F | GGGTATTTGATAAGACGAAGTTCAA | ||
| vvha-R | CTAAGTTCGCACCACACTGTTCG | ||
| tlh-F | TCGCACCAGCTACTCGAAAGATG | ||
| tlh-R | CAACCCCTGTTAGCGCGATGTATT | ||
| nuc-F | GTGCTGGCATATGTATGGCAAT | 658bp | |
| nuc-R | CTGAATCAGCGTTGTCTTCGC |
Contents of each reaction mixture of Multiplex Polymerase Chain Reaction assay.
| Components | Volume |
|---|---|
| 2 Multi HS Prime Taq Premix | 10 μL |
| Primer Mixture | 5 μL |
| Template DNA | 5 μL |
| Total | 20 μL |
Cycling conditions used during multiplex polymerase chain reaction for detection of bacterial genes.
| Step | Temperature | Time | Cycle |
|---|---|---|---|
| UDG reaction | 50°C | 3 min | 1 |
| Pre-denaturation | 95°C | 10 min | 1 |
| Denaturation | 95°C | 30 s | 35 |
| Annealing | 60°C | 20 s | |
| Extension | 72°C | 1 min | |
| Final extension | 72°C | 5 min | 1 |
| Store | 4°C | ∞ | - |
Panel of antibiotics, their concentration, and zone diameter interpretative standards for different bacteria (CLIS, 2011).
| Name of bacteria | Name of Antimicrobial agent (mg) | Disk content (mg) | Interpretation of zone diameters (mm) | ||
|---|---|---|---|---|---|
| R≤ | I | S≥ | |||
| Penicillin | 6 | - | - | - | |
| Ampicillin | 10 | 14 | - | 15 | |
| Amoxicillin | 25 | 14 | - | 15 | |
| Cefotaxime | 30 | 19 | - | 20 | |
| Gentamicin | 10 | 16 | 17-19 | 20 | |
| Ciprofloxacin | 5 | 16 | 17-19 | 20 | |
| Tetracycline | 3 | 19 | 20-23 | 24 | |
| Sulfamethoxazole | 300 | 13 | 14-16 | 17 | |
| Penicillin | 6 | 28 | 20-27 | 19 | |
| Ampicillin | 10 | 20 | - | 19 | |
| Amoxicillin | 25 | - | - | - | |
| Cefotaxime | 30 | - | - | - | |
| Gentamicin | 10 | - | - | - | |
| Ciprofloxacin | 5 | - | - | - | |
| Tetracycline | 3 | 19 | 15-18 | 14 | |
| Sulfamethoxazole | 300 | 16 | 11-15 | 10 | |
| Penicillin | 6 | 12.5 | 1.6-6.2 | 0.8 | |
| Ampicillin | 10 | - | - | - | |
| Amoxicillin | 25 | - | - | - | |
| Cefotaxime | 30 | - | - | - | |
| Gentamicin | 10 | - | - | - | |
| Ciprofloxacin | 5 | - | - | - | |
| Tetracycline | 3 | 12.5 | 3.1-6.2 | 1 0.6 | |
| Sulfamethoxazole | 300 | - | - | - | |
| Penicillin | 6 | 24 | - | 25 | |
| Ampicillin | 10 | 25 | - | 26 | |
| Amoxicillin | 25 | - | - | - | |
| Cefotaxime | 30 | 21 | - | 22 | |
| Gentamicin | 10 | - | - | - | |
| Ciprofloxacin | 5 | 13 | - | 14 | |
| Tetracycline | 3 | 19 | - | 20 | |
| Sulfamethoxazole | 300 | 19 | - | 20 | |
R=Resistant, I=Intermediate S=Sensitive, (-)=No established value found
Figure-1Result of multiplex polymerase chain reaction assay for (a) nuc gene of Staphylococcus aureus identified from the samples; Lane M: 1 Kb DNA marker; Lane N: Negative control; Lane P: Control DNA; Lane 1: Staphylococcus aureus gene-sized (658 bp) amplicon, (b) cpe and cpb2 gene of Clostridium perfringens identify from the samples; Lane M: 1 Kb DNA marker; Lane N: Negative control; Lane P: Control DNA; Lane 1: C. perfringens gene-sized (400 bp) amplicon, (c) prfA gene of Listeria monocytogenes identify from the samples; Lane M: 1 Kb DNA marker; Lane N: Negative control; Lane P: Control DNA; Lane 1: L. monocytogenes gene-sized (150 bp) amplicon, (d) invA gene of Salmonella spp. identify from the samples; Lane M: 1 Kb DNA marker; Lane N: Negative control; Lane P: Control DNA; Lane 2: Salmonella spp. gene-sized (100 bp) amplicon.
Prevalence of microorganisms confirmed by multiplex polymerase chain reaction.
| Name of the microorganisms | Positive (n) | Prevalence | 95% CI |
|---|---|---|---|
| 23 | 11.5% | 7.4-16.7 | |
| 0 | 0 | - | |
| 7 | 3.5% | 1.4-7.1 | |
| 0 | 0 | - | |
| 0 | 0 | - | |
| 0 | 0 | - | |
| 2 | 1% | 0.1-3.6 | |
| 41 | 20.5% | 15.1-26.8 |
Frequency distribution of symptoms due to infection of Staphylococcus aureus in goats.
| Clinical signs and symptoms | N | % |
|---|---|---|
| Mild fever, nasal discharge, dyspnea, and coughing | 09 | 39.1 |
| Fever, lethargy, dehydration, loss of appetite, and parturition history | 08 | 34.8 |
| Mild fever, dry nose, and wheezing | 04 | 17.4 |
| Fever, sneezing, and foaming at the mouth | 02 | 8.7 |
Factors influencing the infection of Staphylococcus aureus in goats.
| Variables | Categories | Multiple logistic regression | |||||
|---|---|---|---|---|---|---|---|
| n (%) | 95% CI | p (χ2-test) | OR | 95% CI | p-value | ||
| Season | Summer (80) | 11 (13.7%) | 7.1-23.3 | 0.42 | |||
| Winter (120) | 12 (10%) | 5.3-16.8 | |||||
| Breed | Black Bengal (25) | 1 (4%) | 0.1-20.3 | 0.02 | 1 | ||
| Jamnapari (133) | 19 (14.3%) | 8.8-21.4 | 1.6 | 0.2-14.2 | 0.67 | ||
| Cross (42) | 3 (7.1%) | 1.5-19.5 | 1.5 | 0.1-18.1 | 0.71 | ||
| Sex | Male (81) | 3 (3.7%) | 0.7-10.4 | 1 | |||
| Female (119) | 20 (16.8%) | 10.6-24.7 | 2.6 | 0.6-10.9 | 0.20 | ||
| Source | Family (146) | 15 (10.3%) | 5.8-16.4 | 0.37 | |||
| Farm (54) | 8 (14.8%) | 6.6-27.1 | |||||
| Age | Juvenile (0 days-1 year) (93) | 4 (4.3%) | 1.2-10.6 | 1 | |||
| Young (1 year-2 years) (71) | 7 (9.8%) | 4.1-19.3 | 1.8 | 0.5-6.9 | 0.39 | ||
| Adult (>2 years) (36) | 12 (33.3%) | 18.6-50.9 | 6 | 1.5-24.5 | |||
| Body condition score | Poor -1 (69) | 4 (5.8%) | 1.6-14.2 | 0.09 | 1 | ||
| Fair-2 (77) | 9 (11.7%) | 5.5-21.1 | 2.4 | 0.6-8.6 | 0.18 | ||
| Good-3 (54) | 10 (18.5%) | 9.3-31.4 | 3.6 | 0.9-13.2 | |||
| Vaccination | Yes (14) | 1 (7.1%) | 0.2-33.8 | 0.59 | |||
| No (186) | 22 (11.8%) | 7.6-17.4 | |||||
Figure-2Antimicrobial resistance pattern of Staphylococcus aureus.
Frequency distribution of symptoms due to infection of Clostridium perfringens in goats.
| Clinical signs and symptoms | N | % |
|---|---|---|
| Diarrhea, convulsion, abdominal pain, and incoordination | 04 | 57.1 |
| Fever, diarrhea, and convulsion | 02 | 28.6 |
| Anorexia, diarrhea with blood, and dehydration | 01 | 17.1 |
Factors influencing the infection of Clostridium perfringens in goats.
| Variables | Categories | Multiple logistic regression | |||||
|---|---|---|---|---|---|---|---|
| n (%) | 95% CI | p (χ2-test) | OR | 95% CI | p-value | ||
| Season | Summer (80) | 2 (2.5) | 0.3-8.7 | 0.53 | |||
| Winter (120) | 5 (4.2) | ||||||
| Breed | Black Bengal (25) | 0 | 0 | ||||
| Jamunapari (133) | 2 (1.5%) | 0.2-5.3 | 1 | ||||
| Cross (42) | 5 (11.9%) | 3.9-25.6 | 4.9 | 0.8-28.7 | 0.08 | ||
| Sex | Female (119) | 1 (0.8%) | 0.1-4.6 | 1 | |||
| Male (81) | 6 (7.4%) | 2.8-15.4 | 5.6 | 0.6-54.1 | 0.13 | ||
| Source | Family (146) | 5 (3.4%) | 1.1-7.8 | 0.92 | |||
| Farm (54) | 2 (3.7%) | 0.5-12.7 | |||||
| Age | Juvenile (0 days-1 year) (93) | 5 (5.4%) | 1.8-12.1 | ||||
| Young (1 year-2 years) (71) | 2 (2.8%) | 0.3-9.8 | |||||
| Adult (> 2 years) (36) | 0 | 0 | |||||
| Body condition score | Poor-1 (69) | 3 (4.3%) | 0.9-12.2 | 0.84 | |||
| Fair- 2 (77) | 2 (2.6%) | 0.3-9.1 | |||||
| Good-3 (54) | 2 (3.7%) | 0.5-12.7 | |||||
| Vaccination | Yes (14) | 0 | 0 | 0.46 | |||
| No (186) | 7 (3.7%) | 1.5-7.6 | |||||
Figure-3Antimicrobial resistance pattern of Clostridium perfringens.
Frequency distribution of symptoms due to infection of Listeria monocytogenes in goats.
| Clinical signs and symptoms | N | % |
|---|---|---|
| Fever, protrusion of tongue and incoordination | 02 | 100 |
Factors influencing the infection of Listeria monocytogenes in goats of Chittagong.
| Variables | Categories | |||
|---|---|---|---|---|
| n (%) | 95% CI | p-value (c2-test) | ||
| Season | Winter (120) | 2 (1.7%) | 0.2-5.9 | 0.24 |
| Summer (80) | 0 | - | ||
| Breed | Jamunapari (133) | 2 (1.5%) | 0.1-5.3 | 0.6 |
| Black Bengal (25) | 0 | |||
| Cross (42) | 0 | |||
| Sex | Female (119) | 0 | 0.08 | |
| Male (81) | 2 (2.5%) | 0.3-8.6 | ||
| Source | Farm (54) | 2 (3.8%) | 0.4-13.2 | |
| Family (146) | 0 | |||
| Age | Juvenile (0 days-1 year) (93) | 1 (1.1%) | 0.03-5.8 | 0.78 |
| Young (1 year-2 years) (71) | 1 (1.4%) | 0.04-7.6 | ||
| Adults (>2 years) (36) | 0 | |||
| Body condition score | Poor-1 (69) | 2 (2.9%) | 0.3-10.1 | 0.15 |
| Fair-2 (77) | 0 | |||
| Good-3 (54) | 0 | |||
| Vaccination | Yes (14) | 0.69 | ||
| No (186) | 2 (1.1%) | 0.1-3.8 | ||
Figure-4Antimicrobial resistance pattern of Listeria monocytogenes.
Frequency distribution of symptoms due to infection of Salmonella spp. in goats.
| Clinical signs and symptoms | N | % |
|---|---|---|
| Fever, anorexia, dehydration, and mucus in stool | 15 | 36.6 |
| Profuse, watery foul-smelling diarrhea, anorexia, and dehydration | 12 | 29.3 |
| High fever, lethargy, and yellow to greenish-brown diarrhea | 07 | 17.1 |
| Mild fever and blood-streaked diarrhea | 04 | 9.7 |
| Mild fever, lethargy, gaseous stomach, and diarrhea | 03 | 7.3 |
Factors influencing the infection of Salmonella spp. in goats.
| Variables | Categories | Multiple logistic regression | |||||
|---|---|---|---|---|---|---|---|
| n (%) | 95% CI | p (c2-test) | OR | 95% CI | p-value | ||
| Season | Winter (120) | 21 (17.5%) | 11.2-25.5 | 0.19 | 1 | ||
| Summer (80) | 20 (25%) | 15.9-35.9 | 1.8 | 0.7-4.4 | 0.24 | ||
| Breed | Jamunapari (133) | 6 (4.5%) | 1.7-9.6 | 1 | |||
| Black Bengal (25) | 11 (44%) | 24.4-65.1 | 22.8 | 6.5-79.9 | |||
| Cross (42) | 24 (57.1%) | 40.9-72.3 | 27.3 | 9.1-81.8 | |||
| Sex | Female (119) | 22 (18.5%) | 11.9-26.6 | 0.39 | |||
| Male (81) | 19 (23.5%) | 14.7-34.2 | |||||
| Source | Farm (54) | 6 (11.1%) | 4.2-22.6 | 1 | |||
| Family (146) | 35 (23.9%) | 17.3-31.7 | 3.1 | 0.9-9.5 | 0.05 | ||
| Age | Juvenile (0 days-1 year) (93) | 18 (19.4%) | 11.9-28.8 | 0.48 | |||
| Young (1 year-2 years) (71) | 13 (18.3%) | 10.1-29.3 | |||||
| Adult (>2 years) (36) | 10 (27.8%) | 14.2-45.2 | |||||
| Body condition score | Poor-1 (54) | 5 (9.3%) | 3.1-20.3 | 0.02 | 1 | ||
| Fair-2 (69) | 14 (20.3%) | 11.6-31.7 | 2.2 | 0.5-8.4 | 0.26 | ||
| Good-3 (77) | 22 (28.6%) | 18.8-40 | 5.7 | 1.5-21.5 | |||
| Vaccination | Yes (14) | 7 (50%) | 23.1-76.9 | 6 | 1.2-31.3 | ||
| No (186) | 34 (18.3%) | 13-24.6 | 1 | ||||
Figure-5Antimicrobial resistance pattern of Salmonella spp.